Epstein Barr Virus (EBV) Reactivation After Reduced Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplantation.

被引：0
|
作者：
Peric, Zinaida [1 ]
Cahu, Xavier [1 ]
Chevallier, Patrice [1 ]
Brissot, Eolia [1 ]
Malard, Florent [1 ]
Guillaume, Thierry [1 ]
Delaunay, Jacques [1 ]
Ayari, Sameh [1 ]
Dubruille, Viviane [1 ]
Le Gouill, Steven [1 ]
Mahe, Beatrice [1 ]
Gastinne, Thomas [1 ]
Blin, Nicolas [1 ]
Saulquin, Beatrice [1 ]
Harrouseau, Jean-Luc [2 ]
Moreau, Philippe [1 ]
Milpied, Noel [3 ]
Coste-Burel, Marianne [4 ]
Imbert-Marcille, Berthe-Marie [4 ]
Mohty, Mohamad [1 ]
机构：
[1] CHU Nantes, Dept Hematol, F-44035 Nantes 01, France
[2] Ctr Reg Lutte Canc CRLCC Rene Gauducheau, St Herblain, France
[3] CHU Bordeaux, Dept Hematol, Bordeaux, France
[4] CHU Nantes, Virol Lab, F-44035 Nantes 01, France
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：539 / 540
页数：2
相关论文
共 50 条
  • [41] Increased Infection Rate After Preemptive Rituximab Treatment for Epstein-Barr Virus Reactivation After Allogeneic Hematopoietic Stem-Cell Transplantation
    Petropoulou, Anna D.
    Porcher, Raphael
    de Latour, Regis Peffault
    Xhaard, Alienor
    Weisdorf, Daniel
    Ribaud, Patricia
    Rodriguez-Otero, Paula
    Agbalika, Felix
    Talbot, Alexis
    Toubert, Antoine
    Moins-Teisserenc, Helene
    Carmagnat, Maryvonnick
    Socie, Gerard
    Robin, Marie
    TRANSPLANTATION, 2012, 94 (08) : 879 - 883
  • [42] Features of Epstein-Barr virus reactivation after reduced-intensity conditioning unrelated umbilical cord blood transplantation
    Peric, Z.
    Chevallier, P.
    Cahu, X.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Dubruille, V.
    Le Gouill, S.
    Mahe, B.
    Gastinne, T.
    Blin, N.
    Saulquin, B.
    Milpied, N.
    Vrhovac, R.
    Harousseau, J. L.
    Moreau, P.
    Coste-Burel, M.
    Imbert-Marcille, B. M.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S236 - S236
  • [43] Late reactivation of Epstein-Barr Virus (EBV) in recipients of non-myeloablative allogeneic stem cell transplantation conditioned with alemtuzumab
    Hill, QA
    Collyns, TA
    Hale, AD
    Fawcett, T
    Hancox, A
    Cook, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 29 - 29
  • [44] The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
    Mardani, Masoud
    Abolghasemi, Sara
    Shabani, Shiva
    Tavakoli, Farzaneh
    Saeedi, Anahita
    Parkhideh, Sayeh
    Hajifathali, Abbas
    IRANIAN JOURNAL OF MICROBIOLOGY, 2020, 12 (06) : 636 - 643
  • [45] PREDICTIVE FACTORS FOR HOSPITALIZATION AFTER OUTPATIENT REDUCED-INTENSITY CONDITIONING (RIC) ALLOGENEIC HEMATOPOIETIC PROGENITOR CELL TRANSPLANTATION (AHPCT)
    Shadman, M.
    Rybicki, L.
    Kalaycio, M.
    Copelan, E.
    Andresen, S.
    Pohlman, B.
    Dean, R.
    Duong, H.
    Bolwell, B.
    Sobecks, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S313 - S314
  • [46] Risk Factors for Graft Failure and Survival after Reduced Intensity (RIC) Conditioning Allogeneic Hematopoietic Cell Transplantation (HUT) for Myelofibrosis
    Glotzbecker, Brett
    Kim, Haesook T.
    Cutler, Corey S.
    Koreth, John
    Armand, Philippe
    Nikiforow, Sarah
    Antin, Joseph H.
    Soiffer, Robert J.
    Alyea, Edwin P., III
    Ho, Vincent T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S34 - S34
  • [47] Cytokine Gene Polymorphisms and Epstein-Barr Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
    Lin, Ren
    Fan, Zhiping
    Zhao, Ke
    Jiang, Qianli
    Sun, Jing
    Liu, Qifa
    BLOOD, 2015, 126 (23)
  • [48] After reduced intensity conditioning (RIC) allogeneic hematopoietic peripheral blood stem cell transplantation (ASCT) reduces red blood cell (RBC) transfusion requirements
    Ivanov, V.
    El Cheikh, J.
    Faucher, C.
    Furst, S.
    Mohty, M.
    Ladaique, P.
    Lemarie, C.
    Charbonnier, A.
    Coso, D.
    Schiano, J. M.
    Viret, F.
    Blaise, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 73 - 73
  • [49] Incidence of and Risk Factors for Cytomegalovirus (CMV), Epstein Barr Virus (EBV) and Adenovirus (ADV) Reactivation in Pediatric Recipients Post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHCT)
    Rustia, Evelyn
    Violago, Leah
    Jin, Zhezhen
    Bhatia, Monica
    Kung, Andrew
    Foca, Marc
    George, Diane
    Garvin, James
    Satwani, Prakash
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S84 - S85
  • [50] Infectious complications in reduced intensity conditioning (RIC) allogeneic stem cell transplantation with antilymphocyte antibodies.
    Lamba, R
    Carrum, G
    Krance, R
    Heslop, H
    Brenner, M
    Popat, U
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 589S - 589S
12345